Endpoint measures in the mdx mouse relevant for muscular dystrophy pre-clinical studies

Neuromuscular Disorders

Volumn 22, Issue 1, 2012, Pages 34-42

  Kobayashi, Yvonne M ^a   Rader, Erik P ^a   Crawford, Robert W ^a   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Ambulation; Biomarkers; Duchenne muscular dystrophy; Mdx; Pre clinical studies

Indexed keywords

CREATINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; LOCOMOTION; MALE; MOUSE; MUSCLE INJURY; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOGLOBINURIA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CREATINE KINASE; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOGLOBINURIA; PHYSICAL CONDITIONING, ANIMAL;

EID: 84855998142     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.08.001     Document Type: Article

References (35)

1. Sena E.S., van der Worp H.B., Bath P.M., Howells D.W., Macleod M.R. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010, 8:e1000344.
2. van der Worp H.B., Howells D.W., Sena E.S., et al. Can animal models of disease reliably inform human studies?. PLoS Med 2010, 7:e1000245.
3. London A.J., Kimmelman J., Emborg M.E. Research ethics. Beyond access vs. protection in trials of innovative therapies. Science 2010, 328:829-830.
4. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
5. Garry D.J., Ordway G.A., Lorenz J.N., et al. Mice without myoglobin. Nature 1998, 395:905-908.
6. Grady R.M., Merlie J.P., Sanes J.R. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 1997, 136:871-882.
7. Kobayashi Y.M., Rader E.P., Crawford R.W., et al. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 2008, 456:511-515.
8. Spurney C.F., Gordish-Dressman H., Guerron A.D., et al. Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 2009, 39:591-602.
9. Thompson S., Lupi D., Hankins M.W., Peirson S.N., Foster R.G. The effects of rod and cone loss on the photic regulation of locomotor activity and heart rate. Eur J Neurosci 2008, 28:724-729.
10. Brooks S.V., Faulkner J.A. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 1988, 404:71-82.
11. Wang R., Urso M.L., Zambraski E.J., Rader E.P., Campbell K.P., Liang B.T. Adenosine A(3) receptor stimulation induces protection of skeletal muscle from eccentric exercise-mediated injury. Am J Physiol Regul Integr Comp Physiol 2010, 299:R259-R267.
12. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997, 139:375-385.
13. McDonald C.M., Henricson E.K., Han J.J., et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2010, 41:500-510.
14. Chao D.S., Silvagno F., Bredt D.S. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 1998, 71:784-789.
15. Crosbie R.H., Straub V., Yun H.Y., et al. Mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 1998, 7:823-829.
16. Bellinger A.M., Reiken S., Carlson C., et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 2009, 15:325-330.
17. Villalta S.A., Nguyen H.X., Deng B., Gotoh T., Tidball J.G. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 2009, 18:482-496.
18. Grady R.M., Teng H., Nichol M.C., Cunningham J.C., Wilkinson R.S., Sanes J.R. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738.
19. Wooddell C.I., Zhang G., Griffin J.B., Hegge J.O., Huss T., Wolff J.A. Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle Nerve 2010, 41:487-499.
20. Pichavant C., Aartsma-Rus A., Clemens P.R., et al. Current status of pharmaceutical and genetic therapetuic approaches to treat DMD. Mol Ther 2011, 19:830-840.
21. McDonald C.M., Widman L.M., Walsh D.D., Walsh S.A., Abresch R.T. Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2005, 86:802-808.
22. Percival J.M., Anderson K.N., Gregorevic P., Chamberlain J.S., Froehner S.C. Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One 2008, 3:e3387.
23. Rafael J.A., Nitta Y., Peters J., Davies K.E. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome 2000, 11:725-728.
24. Buyse G.M., Van der Mieren G., Erb M., et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eur Heart J 2009, 30:116-124.
25. Carter G.T., Wineinger M.A., Walsh S.A., Horasek S.J., Abresch R.T., Fowler W.M. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 1995, 5:323-332.
26. Dupont-Versteegden E.E., McCarter R.J., Katz M.S. Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol 1994, 77:1736-1741.
27. Wineinger M.A., Abresch R.T., Walsh S.A., Carter G.T. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 1998, 77:20-27.
28. Gaudreault N., Gravel D., Nadeau S., Houde S., Gagnon D. Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait Posture 2010, 32:342-347.
29. Collins R.L. On the inheritance of handedness. I. Laterality in inbred mice. J Hered 1968, 59:9-12.
30. Signore P., Chaoui M., Nosten-Bertrand M., Perez-Diaz F., Marchaland C. Handedness in mice: comparison across eleven inbred strains. Behav Genet 1991, 21:421-429.
31. Signore P., Nosten-Bertrand M., Chaoui M., Roubertoux P.L., Marchaland C., Perez-Diaz F. An assessment of handedness in mice. Physiol Behav 1991, 49:701-704.
32. Acharyya S., Villalta S.A., Bakkar N., et al. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007, 117:889-901.
33. Black C.D., McCully K.K. Muscle injury after repeated bouts of voluntary and electrically stimulated exercise. Med Sci Sports Exerc 2008, 40:1605-1615.
34. Hyatt J.P., Clarkson P.M. Creatine kinase release and clearance using MM variants following repeated bouts of eccentric exercise. Med Sci Sports Exerc 1998, 30:1059-1065.
35. Marqueste T., Giannesini B., Fur Y.L., Cozzone P.J., Bendahan D. Comparative MRI analysis of T2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage. J Appl Physiol 2008, 105:299-307.